Cargando…

Association Between Systemic and Pulmonary Vascular Dysfunction in COPD

INTRODUCTION: In chronic obstructive pulmonary disease (COPD), endothelial dysfunction and stiffness of systemic arteries may contribute to increased cardiovascular risk. Pulmonary vascular disease (PVD) is frequent in COPD. The association between PVD and systemic vascular dysfunction has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piccari, Lucilla, Del Pozo, Roberto, Blanco, Isabel, García-Lucio, Jessica, Torralba, Yolanda, Tura-Ceide, Olga, Moises, Jorge, Sitges, Marta, Peinado, Víctor Ivo, Barberà, Joan Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457710/ https://www.ncbi.nlm.nih.gov/pubmed/32904646 http://dx.doi.org/10.2147/COPD.S257679

Ejemplares similares

Circulating Progenitor Cells and Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
por: Pizarro, Sandra, et al.
Publicado: (2014)

Updated Perspectives on Pulmonary Hypertension in COPD
por: Blanco, Isabel, et al.
Publicado: (2020)

Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease
por: Tura-Ceide, Olga, et al.
Publicado: (2019)

Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways
por: Aguilar, Daniel, et al.
Publicado: (2022)

Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD
por: Piccari, Lucilla, et al.
Publicado: (2023)

Atrophy signaling pathways in respiratory and limb muscles of guinea pigs exposed to chronic cigarette smoke: role of soluble guanylate cyclase stimulation
por: Peinado, Víctor Ivo, et al.
Publicado: (2023)

Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease
por: García-Lucio, Jéssica, et al.
Publicado: (2018)

Reply to: COVID-19 and Coagulopathy
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Metabolic Alterations in Cardiopulmonary Vascular Dysfunction
por: Smolders, Valérie Françoise, et al.
Publicado: (2019)

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023)

Slug Is Increased in Vascular Remodeling and Induces a Smooth Muscle Cell Proliferative Phenotype
por: Coll-Bonfill, Núria, et al.
Publicado: (2016)

Correction: Slug Is Increased in Vascular Remodeling and Induces a Smooth Muscle Cell Proliferative Phenotype
por: Coll-Bonfill, Núria, et al.
Publicado: (2016)

Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease
por: Paul, Tanja, et al.
Publicado: (2018)

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023)

Circulating Cell Biomarkers in Pulmonary Arterial Hypertension: Relationship with Clinical Heterogeneity and Therapeutic Response
por: Tura-Ceide, Olga, et al.
Publicado: (2021)

Cigarette smoke challenges bone marrow mesenchymal stem cell capacities in guinea pig
por: Tura-Ceide, Olga, et al.
Publicado: (2017)

Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension
por: Tura-Ceide, Olga, et al.
Publicado: (2021)

Editorial: Metabolic changes in vascular disorders: A path for early diagnosis and new therapeutic targets
por: Ayyoub, Sana, et al.
Publicado: (2023)

Blood Flow Disturbances in Congenital Heart Disease: Is Neuroblastoma Suppressor of Tumorigenicity 1 a Target for Preventing Pulmonary Vascular Remodeling?
por: Tura-Ceide, Olga
Publicado: (2022)

Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension
por: Nukala, Sarath Babu, et al.
Publicado: (2021)

Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis
por: Torres-Castro, Rodrigo, et al.
Publicado: (2021)

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
por: Garcia, Agustin R., et al.
Publicado: (2023)

Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
por: Smolders, V. F. E. D., et al.
Publicado: (2022)

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease
por: Portillo, Karina, et al.
Publicado: (2015)

Endothelial Dysfunction and Cardiovascular Risk in Obstructive Sleep Apnea: A Review Article
por: Peracaula, Miriam, et al.
Publicado: (2022)

Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
por: Kurakula, Kondababu, et al.
Publicado: (2021)

The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression
por: Smolders, Valérie F. E. D., et al.
Publicado: (2021)

Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis
por: Ayyoub, Sana, et al.
Publicado: (2023)

Pulmonary hypertension associated with COPD
por: Naeije, Robert, et al.
Publicado: (2001)

Iron Replacement and Redox Balance in Non-Anemic and Mildly Anemic Iron Deficiency COPD Patients: Insights from a Clinical Trial
por: Pérez-Peiró, Maria, et al.
Publicado: (2021)

Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension
por: Poyatos, Paula, et al.
Publicado: (2023)

New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans
por: Bujak, Renata, et al.
Publicado: (2016)

Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
por: Sibila, Oriol, et al.
Publicado: (2021)

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
por: Nathan, Steven D., et al.
Publicado: (2022)

Generation of a Novel In Vitro Model to Study Endothelial Dysfunction from Atherothrombotic Specimens
por: Gallogly, Susan, et al.
Publicado: (2021)

Pulmonary Dysfunction in COPD
por: Spiropoulos, Kostas, et al.
Publicado: (2013)

Linking In Vitro Models of Endothelial Dysfunction with Cell Senescence
por: Jimenez Trinidad, Francisco R., et al.
Publicado: (2021)

Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig
por: Ferrer, Elisabet, et al.
Publicado: (2009)

Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
por: Yang, Lucy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_urnsb910s0dmd8n5o5tu4hed4u